Isthmus Partners, LLC Biolife Solutions Inc Transaction History
Isthmus Partners, LLC
- $815 Million
- Q3 2024
A detailed history of Isthmus Partners, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Isthmus Partners, LLC holds 132,047 shares of BLFS stock, worth $3.55 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
132,047
Previous 165,247
20.09%
Holding current value
$3.55 Million
Previous $3.54 Million
6.66%
% of portfolio
0.41%
Previous 0.43%
Shares
21 transactions
Others Institutions Holding BLFS
# of Institutions
199Shares Held
45MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$234 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$147 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$86.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$76.5 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$42.4 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.15B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...